212091
Impact of sexual health taboos on the cervical cancer screening behavior of women in Kumasi, Ghana
Cervical cancer is currently the leading cause of cancer death among women in Ghana, West Africa. Visual inspection of the cervix with acetic acid wash (VIA) is an effective screening method that can detect precancerous lesions in the cervix. Data from the International Agency for Research on Cancer's report, Globocon 2002, indicated that the cervical cancer mortality rate in Ghana is nearly twice the cervical cancer mortality rate in the world. Early detection, and treatment of precancerous lesions can prevent the development of cervical cancer, and lower the mortality rate. There are many barriers that prevent women in Ghana from obtaining regular cervical cancer screenings including sexual health taboos. Surveys will be administered (n=75) and focus groups discussions will be conducted with female residents (n = 25) of Kumasi, Ghana. An analysis of the data collected will be used to assess the effect of sexual health taboos on cervical cancer screening. This study will provide significant information that can be used to develop culturally appropriate cervical cancer screening messages that may increase the cervical cancer screening rates in Ghana.
Learning Objectives: At the end of this presentation the participants will be able to:
1. Understand sexual health taboos of women in Kumasi, Ghana that act as barriers to cervical cancer screening.
2. Identify methods of increasing cervical cancer screening rates of women in Kumasi, Ghana.
Keywords: Cervical Cancer, Reproductive Health
Presenting author's disclosure statement:Qualified on the content I am responsible for because: I am pursuing a doctoral degree in Health Promotion, Education, & Behavior. My research interests include cancer prevention and control and cancer disparities among underserved populations.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
|